Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

Clinical trial NCT05628922 · RECRUITING

Trial details

NCT number: NCT05628922
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Cancer

Start date: 2022-07-02
Primary completion: 2026-07-01
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.